Overexpression of SDF-1 in ischemic cardiomyopathy by either engineered cell-based or plasmid-based approach improved cardiac function in rats via enhancing stem cell homing and promoting revascularization of the infarct area (61, 62). The gene discussed is CXCL12; the disease is ischemic cardiomyopathy.